Same-Day PET-Guided Biopsies Rush Preoperative Work-Up for Breast Cancer Patients and Reduce Radiation Exposure
By MedImaging International staff writers Posted on 16 May 2011 |
Clinicians have demonstrated how positron emission mammography (PEM)-guided biopsy may expedite preoperative work-up and reduce radiation exposure for breast cancer patients.
Researchers from the University of Cincinnati (OH, USA) presented their findings from a prospective study at the American Roentgen Ray Society 2011 annual meeting on May 3, 2011, held in Chicago (IL, USA).
PEM scanners are high-resolution breast positron emission tomography (PET) systems that can show the location as well as the metabolic phase of a lesion. This information is crucial in determining whether a lesion is malignant and influences the course of treatment. Naviscan's (San Diego, CA, USA) Stereo Navigator accessory is the first commercialized PET-guided biopsy tool, and has been cleared by the US Food and Drug Administration (FDA) since 2008.
"PEM is useful for performing local staging in women with newly diagnosed breast cancer," stated Dr. Amy Argus, assistant professor of radiology and one of the lead investigators of the study. "When additional breast abnormalities are identified by PEM, accurate PEM-guided biopsy can be performed on the same day as the diagnostic imaging, which decreases the patient's radiation dose and may expedite their preoperative work-up."
In this study, 18 women with breast cancer classified as BIRADS [Breast Imaging-Reporting and Data System]-5 identified on mammography or ultrasound, underwent a PEM scan and same day PEM-guided biopsy on 24 index and satellite lesions. Lesion size was 4 mm - 60 mm with a mean size of 16 mm. Results were concordant for 83% of lesions and discordant for the remaining due to patient movement and operator experience.
PEM is the only technology where physicians are able to biopsy on the same injection of the radiotracer. This is because the radiotracer utilized, fluorodeoxyglucose (FDG), does not washout of the tumor as with other blood flow-dependant modalities like magnetic resonance imaging (MRI) or breast-specific gamma imaging (BSGI). By avoiding a double injection of radiotracer, the radiation exposure to the patient and medical personnel is reduced. Same-day procedures are also feasible with PEM given the ease of interpretation compared to other advanced imaging modalities.
Related Links:
University of Cincinnati
Naviscan
Researchers from the University of Cincinnati (OH, USA) presented their findings from a prospective study at the American Roentgen Ray Society 2011 annual meeting on May 3, 2011, held in Chicago (IL, USA).
PEM scanners are high-resolution breast positron emission tomography (PET) systems that can show the location as well as the metabolic phase of a lesion. This information is crucial in determining whether a lesion is malignant and influences the course of treatment. Naviscan's (San Diego, CA, USA) Stereo Navigator accessory is the first commercialized PET-guided biopsy tool, and has been cleared by the US Food and Drug Administration (FDA) since 2008.
"PEM is useful for performing local staging in women with newly diagnosed breast cancer," stated Dr. Amy Argus, assistant professor of radiology and one of the lead investigators of the study. "When additional breast abnormalities are identified by PEM, accurate PEM-guided biopsy can be performed on the same day as the diagnostic imaging, which decreases the patient's radiation dose and may expedite their preoperative work-up."
In this study, 18 women with breast cancer classified as BIRADS [Breast Imaging-Reporting and Data System]-5 identified on mammography or ultrasound, underwent a PEM scan and same day PEM-guided biopsy on 24 index and satellite lesions. Lesion size was 4 mm - 60 mm with a mean size of 16 mm. Results were concordant for 83% of lesions and discordant for the remaining due to patient movement and operator experience.
PEM is the only technology where physicians are able to biopsy on the same injection of the radiotracer. This is because the radiotracer utilized, fluorodeoxyglucose (FDG), does not washout of the tumor as with other blood flow-dependant modalities like magnetic resonance imaging (MRI) or breast-specific gamma imaging (BSGI). By avoiding a double injection of radiotracer, the radiation exposure to the patient and medical personnel is reduced. Same-day procedures are also feasible with PEM given the ease of interpretation compared to other advanced imaging modalities.
Related Links:
University of Cincinnati
Naviscan
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more